Amarin (AMRN) Stock: Gaining On Priority Review

Amarin AMRN Stock News

Amarin Corporation plc (NASDAQ: AMRN) is having an incredibly strong start to the trading session this morning, and for good reason. The company announced that the FDA has granted priority review, exciting investors and sending the stock for the top. Today, we’ll talk about: The regulatory update; what we’re seeing from AMRN stock as a … Read more

Atossa Genetics (ATOS) Stock: Gaining On Institutional Review Board News

Atossa Therapeutics ATOS Stock News

Atossa Genetics Inc (NASDAQ: ATOS) is making a run for the top in the market this morning, and for good reason. The company announced a positive result from an Institutional Review Board (IRB) review. Of course, the news excited investors, pushing the stock for the top. Today, we’ll talk about: The IRB news; what we’re … Read more

Akari Therapeutics (AKTX) Stock: Continues Skyward On Regulatory News

Akari Therapeutics AKTX Stock News

Akari Therapeutics PLC (NASDAQ: AKTX) is having a great start to the trading session this morning, following up on the strong gains that we saw on the stock yesterday. The gains come after the comapny announced regulatory news, setting the stage for a pivotal clinical trial. Today, we’ll talk about: The regulatory news that started … Read more

IntelliPharmaCeutics (IPCI) Stock: Climbing On NDA Resubmission

IntelliPharmaCeutics IPCI Stock News

IntelliPharmaCeutics Intl Inc (NASDAQ: IPCI) is headed for the top in the market this morning, and for good reason. In an SEC filing, the company announced the resubmission of a New Drug Application with the United States Food and Drug Administration. As you could imagine, the news proved to be a source of excitement for … Read more

Portola Pharmaceuticals (PTLA) Stock: Headed For The Top On A Regulatory Update

Portola Pharmaceuticals PTLA Stock News

Portola Pharmaceuticals Inc (NASDAQ: PTLA) is having a great start to the trading session this morning, and for good reason. The company announced that the European Medicines Agency’s committee had a positive opinion with regard to its drug. Of course, the news is proving exciting to investors, who are sending the stock up. Today, we’ll … Read more

Arca Biopharma (ABIO) Stock: Screaming For The Top On FDA News

Arca Biopharma ABIO Stock News

Arca Biopharma Inc (NASDAQ: ABIO) is having an incredibly strong start to the trading session, gaining in multiples in the pre-market. The gains come after the company announced news from the FDA. Of course, the news was positive, exciting investors and sending the stock on a run for the top. Today, we’ll talk about: The FDA news; … Read more

CorMedix (CRMD) Stock: Declines May Represent An Opportunity!

CorMedix Inc. (NYSEAMERICAN: CRMD) is having an incredibly rough day in the market today, and for good reason. The company updated investors with regard to a meeting that took place with the FDA. Unfortunately, the meeting didn’t go quite as investors hoped. Nonetheless, these declines may represent an opportunity at a discount. Today, we’ll talk … Read more

Omeros (OMER) Stock: Flying On Regulatory Update

Omeros Corporation (NASDAQ: OMER) is heading up in the market this morning, and for good reason. The company announced a regulatory update, exciting investors and sending the stock on a run for the top. Today, we’ll talk about: The regulatory update; what we’re seeing from OMER stock as a result; and what we’ll be watching … Read more

DBV Technologies (DBVT) Stock: Climbing On Regulatory Announcement

DBV Technologies (NASDAQ: DBVT) is having an incredibly strong start to the trading session this morning, and for good reason. The company announced the planned resubmission of a BLA to the United States FDA. Of course, the news excited investors, pushing the stock upward. Today, we’ll talk about: The coming BLA resubmission; what we’re seeing … Read more